Skip to main content

SAGE Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Sage Therapeutics Inc. News

Biogen Beats on Third Quarter Earnings and Raises Guidance

Biogen posts third-quarter earnings that beat forecasts and also ups its full-year profit forecast amid strong expected demand for its Alzheimer's treatment drug.

Premarket Movers Tuesday: Sage Therapeutics, MicroStrategy

Stocks moving in premarket trading Tuesday include Sage Therapeutics, Freeport-McMoRan, MicroStrategy, ContextLogic and Fastenal.

Sage Therapeutics Plunges After Depression Drug-Trial Results

Sage Therapeutics shares plunge following disappointing test results for its depression drug Zuranolone that it is producing with drug giant Biogen.

Sage Falls as Some Patients Drop Out of Tremor Treatment Study

Nearly 40% of patients left a Sage Therapeutics study of a treatment for tremors due to side effects.

Sage Therapeutics Rises After Swing to Profit on Biogen Deal

Sage Therapeutics traded higher after the biopharma posted a fourth-quarter profit, benefiting from its collaboration with Biogen.

Breaking News

Roe Decision Forces Disney, Netflix to Take a Political Stand

Disney, JP Morgan Chase, and outgoing Meta COO Sheryl Sandberg are just a few speaking out against the ruling.

Netflix Lays Offs More Employees To Cut Costs

Netflix layoffs continue as the streaming giant executes a plan to cope with slow revenue growth.

These Five Things Could Help (or Hurt) Internet Stocks

Bank of America analysts outline some of the biggest issues facing Amazon, Alphabet, Meta and other internet-related stocks.